HALO Halozyme Therapeutics

• None no insider bought on the open market
• $2M sold by 1 insider outside a trading plan
• $46.1M sold by 4 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Helen Torley CEO
   Planned sale
   $6.6M 60,000 shares at $110.18 7.2% of stake
   Traded Oct 6–8 Filed Oct 8
   ↗
3. Matthew L. Posard Director
   Planned sale
   $568K 5,230 shares at $108.54 8.9% of stake
   Traded Oct 1 Filed Oct 2
   ↗
4. Matthew L. Posard Director
   Planned sale
   $2M 18,996 shares at $107.74 24% of stake
   Traded Sep 16 Filed Sep 17
   ↗
5. Helen Torley CEO
   Planned sale
   $6.4M 60,000 shares at $107.28 7.2% of stake
   Traded Sep 9–11 Filed Sep 11
   ↗
6. Helen Torley CEO
   Planned sale
   $6.3M 60,000 shares at $104.59 7.2% of stake
   Traded Aug 17–19 Filed Aug 19
   ↗
7. Bernadette Connaughton Director
   Planned sale
   $167K 1,626 shares at $102.80 3.9% of stake
   Traded Aug 10 Filed Aug 11
   ↗
8. Helen Torley CEO
   Planned sale
   $153K 1,923 shares at $79.77 0.2% of stake
   Traded Jul 8 Filed Jul 9
   ↗
9. Bernadette Connaughton Director
   Planned sale
   $125K 1,625 shares at $76.71 3.7% of stake
   Traded Jul 1 Filed Jul 2
   ↗
10. Mahesh Krishnan Director
    Planned sale
    $548K 7,304 shares at $75.00 34% of stake
    Traded Jun 29 Filed Jun 30
    ↗
11. Helen Torley CEO
    Planned sale
    $3.4M 50,000 shares at $67.40 6.1% of stake
    Traded Jun 1–3 Filed Jun 3
    ↗
12. Bernadette Connaughton Director
    Planned sale
    $108K 1,625 shares at $66.21 3.6% of stake
    Traded Jun 1 Filed Jun 2
    ↗
13. Helen Torley CEO
    Planned sale
    $3.4M 50,000 shares at $68.68 6.1% of stake
    Traded May 11–13 Filed May 13
    ↗
14. Bernadette Connaughton Director
    Planned sale
    $103K 1,625 shares at $63.48 4.1% of stake
    Traded May 1 Filed May 5
    ↗
15. Helen Torley CEO
    Planned sale
    $635K 10,000 shares at $63.50 1.3% of stake
    Traded Apr 6 Filed Apr 7
    ↗
16. Helen Torley CEO
    Planned sale
    $2.6M 40,000 shares at $64.81 5% of stake
    Traded Apr 1–2 Filed Apr 2
    ↗

Also filed in the last 12 months, not counted as buying or selling: 51 option exercises, 18 share withholdings for taxes, 9 stock grants, 1 gift, and 1 sale to cover taxes.